1. Tan, E.M., Cohen, A.S., Fries, J.F., Meshane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 100, 714–727.
2. Ginzler, E.M., Diamond, H.S., Weiner, M., Schlesinger, M., Fries, J.F., Wasner, C., Medsger, T.A., Ziegler, G., Klippel, J.M., Hadler, N.M., Albert, D.A., Hess, E.V., Spencer-Green, G., Grayzel, A., Worth, D., Hahn, B.H., Barnett, E.V. A multicenter study of outcome in systemic lupus erythematosus. I: Entry variables as predictors of prognosis. Arthritis Rheum 1982, 25, 601–611.
3. Dimant, J., Ginzler, E., Schlesinger, M., Sterba, G., Diamond, H., Kaplan, D., Weiner, M. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus. Arthritis Rheum 1979, 22, 815–819.
4. Davis, B.M., Gilliam, J.N. Prognostic significance of subepidermal immune deposits in uninvolved skin of patients with systemic lupus erythematosus: A 10 year longitudinal study. J Invest Dermatol 1984, 83, 242–247.
5. Ludovico, C.L., Zweiman, B., Myers, A.R., Herbert, J., Green, P.A. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus. J Rheumatol 1980, 7, 843–849.